237
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Colonic mucosa-associated lymphoid tissue lymphoma: a case series

, , , , , , , , , & show all
Pages 582-587 | Received 12 Jul 2019, Accepted 22 Oct 2019, Published online: 06 Nov 2019

References

  • Chang SC. Clinical features and management of primary colonic lymphoma. Formos J Surg. 2012;45(3):73–77.
  • Kanneganti K, Balar B. Mucosa-associated lymphoid tissue lymphoma presenting as massive gastrointestinal bleeding: a case report. Case Rep Gastroenterol. 2008;2(3):296–300.
  • Adams KM, Roe NM. A rare case of MALT lymphoma underlying ileocecal intussusception. J Am Osteopath Assoc. 2016;116(8):e37–e40.
  • Jain V, Misra S, Ahmad F, et al. MALT lymphoma of caecum presenting as acute intestinal obstruction: a case report. Indian J Surg. 2013;75(S1):286–289.
  • Tankovic J, Chaumette-Planckaert M-T, Deforges L, et al. Routine use of real-time PCR for detection of Helicobacter pylori and of clarithromycin resistance mutations. Gastroenterol Clin Biol. 2007;31(10):792–795.
  • Lévy M, Copie-Bergman C, Molinier-Frenkel V, et al. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up. Leuk Lymphoma. 2010;51(2):284–290.
  • Campo E, Swerdlow SH, Harris NL, Pileri S, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–5032.
  • Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut. 2003;52(11):1656.
  • Copie-Bergman C, Wotherspoon C, Capella C, et al. GELA histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol. 2013;160(1):47–52.
  • Diamantopoulos P, Dryllis G, Tsourouflis G, et al. A unique case of primary extranodal marginal zone lymphoma of the anal canal. Acta Haematol. 2019;142(2):87–91.
  • Li B, Shi YK, He XH, et al. Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol. 2008;87(4):375–381.
  • Kelley SR. Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature. Int J Colorectal Dis. 2017;32(3):295–304.
  • Yoshino T, Ichimura K, Mannami T, et al. Multiple organ mucosa-associated lymphoid tissue lymphomas often involve the intestine. Cancer. 2001;91(2):346–353.
  • Lévy M, Hammel P, Lamarque D, et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc. 1997;46(4):328–333.
  • Matsuo S, Mizuta Y, Hayashi T, et al. Mucosa-associated lymphoid tissue lymphoma of the transverse colon: a case report. World J Gastroenterol. 2006;12(34):5573–5576.
  • Kim MH, Jung JT, Kim EJ, et al. A case of mucosa-associated lymphoid tissue lymphoma of the sigmoid colon presenting as a semipedunculated polyp. Clin Endosc. 2014;47(2):192–196.
  • Nakase H, Okazaki K, Ohana M, et al. The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. Pylori-negative patients. Endoscopy. 2002;34(4):343–346.
  • Matsumoto T, Iida M, Shimizu M. Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet. 1997;350(9071):115–116.
  • Abbas H, Niazi M, Makker J. Mucosa-associated lymphoid tissue (MALT) lymphoma of the colon: a case report and a literature review. Am J Case Rep. 2017;18:491–497.
  • Lévy M, Copie-Bergman C, Amiot A, et al. Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study. Leuk Lymphoma. 2013;54(5):940–944.
  • Zucca E, Conconi A, Martinelli G, et al. Final results of the IELSG-19 randomized trial of mucosa-associated lymphoidtissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy. J Clin Oncol. 2017;35(17):1905–1912.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.